Publications by authors named "T Rubinek"

Article Synopsis
  • Patients with metastatic breast cancer often develop resistance to endocrine therapies, and in some cases, this is linked to mutations in the estrogen receptor-α (ESR1) that can lead to worse outcomes.
  • Research using MCF-7 cells with common ESR1 mutations showed that these cells are more resistant to chemotherapy drugs, as evidenced by higher survival rates and lower levels of cell death compared to cells with wild-type ESR1.
  • The study identified that the JNK/c-Jun/MDR1 pathway is involved in this chemoresistance, indicating that targeting this pathway may provide new treatment strategies for breast cancer patients with ESR1 mutations.
View Article and Find Full Text PDF

Breast cancer (BC) is associated with type 2 diabetes mellitus (T2DM) and obesity. Glucagon-like peptide (GLP)-1 regulates post-prandial insulin secretion, satiety, and gastric emptying. Several GLP-1 analogs have been FDA-approved for the treatment of T2DM and obesity.

View Article and Find Full Text PDF

Klotho, a 1012 amino acid transmembrane protein, is a potent tumor suppressor in different cancer types. Klotho is composed of two internal repeats KL1 and KL2, and the tumor suppressor activity is primarily attributed to the KL1 domain. Despite its significant role in regulating various cancer-related pathways, the precise mechanism underlying its tumor suppressor activity remains unresolved.

View Article and Find Full Text PDF

Background And Objectives: Antileucine-rich glioma-inactivated 1 (anti-LGI1) autoimmune encephalitis was first described in 2010 and is today the most common type of limbic encephalitis. During the course of the disease, 60%-88% of the patients develop hyponatremia. The etiology of the sodium disorder is unclear, often presumed to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

View Article and Find Full Text PDF

Unlabelled: Multiple studies have identified metabolic changes within the tumor and its microenvironment during carcinogenesis. Yet, the mechanisms by which tumors affect the host metabolism are unclear. We find that systemic inflammation induced by cancer leads to liver infiltration of myeloid cells at early extrahepatic carcinogenesis.

View Article and Find Full Text PDF